Zimmer Biomet Holdings, Inc. (ZBH)
NYSE: ZBH · Real-Time Price · USD
91.46
-0.28 (-0.31%)
At close: Jun 27, 2025, 4:00 PM
91.46
0.00 (0.00%)
After-hours: Jun 27, 2025, 7:00 PM EDT
Zimmer Biomet Holdings Revenue
Zimmer Biomet Holdings had revenue of $1.91B in the quarter ending March 31, 2025, with 1.05% growth. This brings the company's revenue in the last twelve months to $7.70B, up 3.30% year-over-year. In the year 2024, Zimmer Biomet Holdings had annual revenue of $7.68B with 3.85% growth.
Revenue (ttm)
$7.70B
Revenue Growth
+3.30%
P/S Ratio
2.37
Revenue / Employee
$452,853
Employees
17,000
Market Cap
18.10B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 7.68B | 284.40M | 3.85% |
Dec 31, 2023 | 7.39B | 454.30M | 6.55% |
Dec 31, 2022 | 6.94B | 112.60M | 1.65% |
Dec 31, 2021 | 6.83B | 699.80M | 11.42% |
Dec 31, 2020 | 6.13B | -1.85B | -23.24% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
ZBH News
- 4 weeks ago - Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2025 - PRNewsWire
- 4 weeks ago - Zimmer Biomet Appoints Kevin Thornal as Group President, Global Businesses and the Americas - PRNewsWire
- 5 weeks ago - Zimmer Biomet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference - PRNewsWire
- 7 weeks ago - These Analysts Lower Their Forecasts On Zimmer Biomet After Q1 Results - Benzinga
- 7 weeks ago - Zimmer Biomet: Stronger Cash Flows Needed Before The Stock Rebounds - Seeking Alpha
- 7 weeks ago - Hip Implant Maker Zimmer Biomet Cuts Annual Profit Forecast On Paragon 28 Deal - Benzinga
- 7 weeks ago - Zimmer Biomet Holdings, Inc. (ZBH) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Zimmer Biomet lowers 2025 profit forecast on acquisition costs, tariff uncertainty - Reuters